Literature DB >> 18483240

The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.

Azadeh Golipour1, Dorothy Myers, Tiffany Seagroves, Daniel Murphy, Gerard I Evan, Daniel J Donoghue, Roger A Moorehead, Lisa A Porter.   

Abstract

Spy1A is a unique cell cycle activator known to mediate cell cycle progression and override the DNA damage response. This study focused on determining the role of this protein on postnatal mammary gland morphogenesis and neoplasia. Herein, we show that Spy1A levels are tightly regulated during mammary gland development and that ectopic expression stimulates precocious development and results in disrupted morphology of the gland. This follows the same trend as the oncogene c-Myc, and we show that Spy1A expression is regulated downstream of c-Myc signaling. Importantly, we show that overexpression of Spy1A accelerates tumorigenesis in vivo. Collectively, this work is the first report that the Spy1/RINGO family of proteins may play an essential role in regulating both normal and abnormal growth processes in the breast.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483240     DOI: 10.1158/0008-5472.CAN-07-6453

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Atypical cell cycle control over neural cell fate.

Authors:  Dorota Lubanska; Lisa A Porter
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells.

Authors:  Li Zhang; Aiguo Shen; Qing Ke; Wei Zhao; Meijuan Yan; Chun Cheng
Journal:  J Mol Neurosci       Date:  2012-03-25       Impact factor: 3.444

3.  Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.

Authors:  Denise A McGrath; Bre-Anne Fifield; Aimee H Marceau; Sarvind Tripathi; Lisa A Porter; Seth M Rubin
Journal:  EMBO J       Date:  2017-06-30       Impact factor: 11.598

4.  Protective roles and Pap1-dependent regulation of the Schizosaccharomyces pombe spy1 gene under nitrosative and nutritional stresses.

Authors:  Min-Hee Kang; Hyun-Joo Jung; Dong-Hoon Hyun; Eun-Hee Park; Chang-Jin Lim
Journal:  Mol Biol Rep       Date:  2010-06-19       Impact factor: 2.316

5.  Spy1 Protein Mediates Phosphorylation and Degradation of SCG10 Protein in Axonal Degeneration.

Authors:  Yonghua Liu; Youhua Wang; Ying Chen; Xiaohong Li; Jiao Yang; Yang Liu; Aiguo Shen
Journal:  J Biol Chem       Date:  2015-04-13       Impact factor: 5.157

6.  CRMP1 Interacted with Spy1 During the Collapse of Growth Cones Induced by Sema3A and Acted on Regeneration After Sciatic Nerve Crush.

Authors:  Li Yao; Yong-Hua Liu; Xiaohong Li; Yu-Hong Ji; Xiao-Jing Yang; Xian-Ting Hang; Zong-Mei Ding; Fang Liu; You-Hua Wang; Ai-Guo Shen
Journal:  Mol Neurobiol       Date:  2014-12-20       Impact factor: 5.590

7.  Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.

Authors:  Masahiro Shitani; Shigeru Sasaki; Noriyuki Akutsu; Hideyasu Takagi; Hiromu Suzuki; Masanori Nojima; Hiroyuki Yamamoto; Takashi Tokino; Koichi Hirata; Kohzoh Imai; Minoru Toyota; Yasuhisa Shinomura
Journal:  Tumour Biol       Date:  2012-03-29

Review 8.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

9.  Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.

Authors:  Mohammad Al Sorkhy; Bre-Anne Fifield; Dorothy Myers; Lisa A Porter
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

10.  The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis.

Authors:  Christopher W McAndrew; Randy F Gastwirt; Daniel J Donoghue
Journal:  Cell Cycle       Date:  2009-01-17       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.